ProMIS Neurosciences (TSE:PMN) Shares Down 0.3%
mid-day trading, a decline of 80% from the average daily volume of 12,865 shares. The stock had previously closed at C$8.95. The stock price for ProMIS Neurosciences, Inc. dropped by 0.3% on Friday, trading as low as $8.78 per share.
The stock price of ) dropped by 0.3% on the Friday. The stock price of the company dropped to C$8.78 before trading at C$8.92. A total of 2,675 shares were traded during the trading session, a 35% increase from the daily average of 1,982 stocks. The stock closed previously at C$8.95.
ProMIS Neurosciences Stock Performance
The 50-day moving average of the stock is C$7.04; its 200-day moving average is C$7.12. The company's current ratio is 1.08, its quick ratio is 1.30 and its debt-to equity ratio is 108.33. The company last released its earnings on March 8th. The company reported C$1.22 EPS for the third quarter. Analysts predict that ProMIS Neurosciences, Inc., as a whole, will report -2.33 EPS for the current fiscal.
ProMIS Neurosciences
Get Rating
)
ProMIS Neurosciences, Inc. discovers and develops precise medicine solutions in Canada for neurodegenerative diseases, primarily Alzheimer's disease, amyotrophic lateral sclerosis, and multiple systematrophy. The company's proprietary platform consists of ProMIS and collective coordinates algorithms that predict novel targets, known as disease-specific epitopes, on the molecular surfaces of misfolded protein.
MarketBeat.com offers a FREE daily email newsletter
.